[The 40th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 43rd Survey in 2017)].

This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2017 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 981 institutions among 1,231 to which the questionnaire had been sent. Twelve cases of adverse reactions were reported. A total of 1,028,886 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.2. No case of deficient products was reported.